| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.00064 | 1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.00099 | 1 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.00081 | 1 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.00057 | 1 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.00052 | 1 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.00042 | 1 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.00053 | 1 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.00045 | 1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.00062 | 1 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.0003 | 1 |